The emerging role of endothelin-1 in the pathogenesis of subchondral bone disturbance and osteoarthritis

Osteoarthritis and Cartilage

Volumn 23, Issue 4, 2015, Pages 516-524

  Sin, A ^a,c   Tang, W ^a   Wen, C Y ^a   Chung, S K ^a,b   Chiu, K Y ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Endothelin 1; Osteoarthritis; Subchondral bone

Indexed keywords

COLLAGENASE 3; ENDOTHELIN 1; INTERSTITIAL COLLAGENASE; CYTOKINE;

ARTICULAR CARTILAGE; CARTILAGE CELL; ENZYMATIC DEGRADATION; ENZYME SYNTHESIS; HUMAN; MOLECULAR PATHOLOGY; NONHUMAN; OSSIFICATION; OSTEOARTHRITIS; OSTEOSCLEROSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SUBCHONDRAL BONE SCLEROSIS; SYNOVIOCYTE; BONE DEVELOPMENT; BONE REMODELING; CARTILAGE; PATHOPHYSIOLOGY; PHYSIOLOGY; SCLEROSIS;

BONE REMODELING; CARTILAGE; CHONDROCYTES; CYTOKINES; ENDOTHELIN-1; HUMANS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 13; OSTEOARTHRITIS; OSTEOGENESIS; SCLEROSIS; SIGNAL TRANSDUCTION;

EID: 84924809471     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2014.11.002     Document Type: Review

References (93)

1. Lories R.J., Luyten F.P. The bone-cartilage unit in osteoarthritis. Nat Rev Rheumatol 2011, 7(1):43-49.
2. Wang Q., Rozelle A.L., Lepus C.M., Scanzello C.R., Song J.J., Larsen D.M., et al. Identification of a central role for complement in osteoarthritis. Nat Med 2011, 17(12):1674-1679.
3. Zhen G., Wen C., Jia X., Li Y., Crane J.L., Mears S.C., et al. Inhibition of TGF-beta signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis. Nat Med 2013, 19(6):704-712.
4. Berenbaum F., Eymard F., Houard X. Osteoarthritis, inflammation and obesity. Curr Opin Rheumatol 2013, 25(1):114-118.
5. Berenbaum F. Diabetes-induced osteoarthritis: from a new paradigm to a new phenotype. Postgrad Med J 2012, 88(1038):240-242.
6. Wen C.Y., Chen Y., Tang H.L., Yan C.H., Lu W.W., Chiu K.Y. Bone loss at subchondral plate in knee osteoarthritis patients with hypertension and type 2 diabetes mellitus. Osteoarthritis Cartilage 2013 Nov, 21(11):1716-1723.
7. Redlich K., Smolen J.S. Inflammatory bone loss: pathogenesis and therapeutic intervention. Nat Rev Drug Discov 2012, 11(3):234-250.
8. Massicotte F., Lajeunesse D., Benderdour M., Pelletier J.P., Hilal G., Duval N., et al. Can altered production of interleukin-1beta, interleukin-6, transforming growth factor-beta and prostaglandin E(2) by isolated human subchondral osteoblasts identify two subgroups of osteoarthritic patients. Osteoarthritis Cartilage 2002, 10(6):491-500.
9. Clines G.A., Mohammad K.S., Grunda J.M., Clines K.L., Niewolna M., McKenna C.R., et al. Regulation of postnatal trabecular bone formation by the osteoblast endothelin A receptor. JBone Min Res 2011, 26(10):2523-2536.
10. Haq A., El-Ramahi K., Al-Dalaan A., Al-Sedairy S.T. Serum and synovial fluid concentrations of endothelin-1 in patients with rheumatoid arthritis. JMed 1999, 30(1-2):51-60.
11. Yoshida H., Imafuku Y., Ohhara M., Miyata M., Kasukawa R., Ohsumi K., et al. Endothelin-1 production by human synoviocytes. Ann Clin Biochem 1998, 35(Pt 2):290-294.
12. Nahir A.M., Hoffman A., Lorber M., Keiser H.R. Presence of immunoreactive endothelin in synovial fluid: analysis of 22 cases. JRheumatol 1991, 18(5):678-680.
13. Khatib A.M., Lomri A., Mitrovic R.D., Moldovan F. Articular chondrocyte aging and endothelin-1. Cytokine 2007, 37(1):6-13.
14. Manacu C.A., Martel-Pelletier J., Roy-Beaudry M., Pelletier J.P., Fernandes J.C., Shipkolye F.S., et al. Endothelin-1 in osteoarthritic chondrocytes triggers nitric oxide production and upregulates collagenase production. Arthritis Res Ther 2005, 7(2):R324-R332.
15. Roy-Beaudry M., Martel-Pelletier J., Pelletier J.P., M'Barek K.N., Christgau S., Shipkolye F., et al. Endothelin 1 promotes osteoarthritic cartilage degradation via matrix metalloprotease 1 and matrix metalloprotease 13 induction. Arthritis Rheum 2003, 48(10):2855-2864.
16. Schneider J.G., Tilly N., Hierl T., Sommer U., Hamann A., Dugi K., et al. Elevated plasma endothelin-1 levels in diabetes mellitus. Am J Hypertens 2002, 15(11):967-972.
17. Yanagisawa M., Inoue A., Ishikawa T., Kasuya Y., Kimura S., Kumagaye S., et al. Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide. Proc Natl Acad Sci U S A 1988, 85(18):6964-6967.
18. Levin E.R. Endothelins. NEngl J Med 1995, 333(6):356-363.
19. Simonson M.S., Dunn M.J. Cellular signaling by peptides of the endothelin gene family. FASEB J 1990, 4(12):2989-3000.
20. Vanhoutte P.M. Endothelin-1. A matter of life and breath. Nature 1994, 368(6473):693-694.
21. Vanhoutte P.M. Is endothelin involved in the pathogenesis of hypertension?. Hypertension 1993, 21(6 Pt 1):747-751.
22. Leung J.W., Wong W.T., Koon H.W., Mo F.M., Tam S., Huang Y., et al. Transgenic mice over-expressing ET-1 in the endothelial cells develop systemic hypertension with altered vascular reactivity. PLoS One 2011, 6(11):e26994.
23. Krum H., Viskoper R.J., Lacourciere Y., Budde M., Charlon V. The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators. NEngl J Med 1998, 338(12):784-790.
24. Oliver F.J., de la Rubia G., Feener E.P., Lee M.E., Loeken M.R., Shiba T., et al. Stimulation of endothelin-1 gene expression by insulin in endothelial cells. JBiol Chem 1991, 266(34):23251-23256.
25. Ottosson-Seeberger A., Lundberg J.M., Alvestrand A., Ahlborg G. Exogenous endothelin-1 causes peripheral insulin resistance in healthy humans. Acta Physiol Scand 1997, 161(2):211-220.
26. Alvarez D., Briassouli P., Clancy R.M., Zavadil J., Reed J.H., Abellar R.G., et al. Anovel role of endothelin-1 in linking Toll-like receptor 7-mediated inflammation to fibrosis in congenital heart block. JBiol Chem 2011, 286(35):30444-30454.
27. Zhang W., Wang W., Yu H., Zhang Y., Dai Y., Ning C., et al. Interleukin 6 underlies angiotensin II-induced hypertension and chronic renal damage. Hypertension 2012, 59(1):136-144.
28. Mayyas F., Niebauer M., Zurick A., Barnard J., Gillinov A.M., Chung M.K., et al. Association of left atrial endothelin-1 with atrial rhythm, size, and fibrosis in patients with structural heart disease. Circ Arrhythm Electrophysiol 2010, 3(4):369-379.
29. Lagares D., Garcia-Fernandez R.A., Jimenez C.L., Magan-Marchal N., Busnadiego O., Lamas S., et al. Endothelin 1 contributes to the effect of transforming growth factor beta1 on wound repair and skin fibrosis. Arthritis Rheum 2010, 62(3):878-889.
30. Shi-Wen X., Rodriguez-Pascual F., Lamas S., Holmes A., Howat S., Pearson J.D., et al. Constitutive ALK5-independent c-Jun N-terminal kinase activation contributes to endothelin-1 overexpression in pulmonary fibrosis: evidence of an autocrine endothelin loop operating through the endothelin A and B receptors. Mol Cell Biol 2006, 26(14):5518-5527.
31. Kambas K., Chrysanthopoulou A., Kourtzelis I., Skordala M., Mitroulis I., Rafail S., et al. Endothelin-1 signaling promotes fibrosis invitro in a bronchopulmonary dysplasia model by activating the extrinsic coagulation cascade. JImmunol 2011, 186(11):6568-6575.
32. Widyantoro B., Emoto N., Nakayama K., Anggrahini D.W., Adiarto S., Iwasa N., et al. Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition. Circulation 2010, 121(22). 2407-U88.
33. Pache M., Schwarz H.A., Kaiser H.J., Wuest P., Kloti M., Dubler B., et al. Elevated plasma endothelin-1 levels and vascular dysregulation in patients with rheumatoid arthritis. Med Sci Monit 2002, 8(9):CR616-CR619.
34. Leask A. Signaling in fibrosis: targeting the TGF beta, endothelin-1 and CCN2 axis in scleroderma. Front Biosci (Elite Ed) 2009, 1:115-122.
35. Leung J.W., Chung S.S., Chung S.K. Endothelial endothelin-1 over-expression using receptor tyrosine kinase tie-1 promoter leads to more severe vascular permeability and blood brain barrier breakdown after transient middle cerebral artery occlusion. Brain Res 2009, 1266:121-129.
36. Iwabuchi H., Kasama T., Hanaoka R., Miwa Y., Hatano Y., Kobayashi K., et al. Downregulation of intercellular adhesion molecule-1 expression on human synovial fibroblasts by endothelin-1. JRheumatol 1999, 26(3):522-531.
37. Schwarting A., Schlaak J., Lotz J., Pfers I., Meyer zum Buschenfelde K.H., Mayet W.J. Endothelin-1 modulates the expression of adhesion molecules on fibroblast-like synovial cells (FLS). Scand J Rheumatol 1996, 25(4):246-256.
38. Conte Fde P., Barja-Fidalgo C., Verri W.A., Cunha F.Q., Rae G.A., Penido C., et al. Endothelins modulate inflammatory reaction in zymosan-induced arthritis: participation of LTB4, TNF-alpha, and CXCL-1. JLeukoc Biol 2008, 84(3):652-660.
39. Kuryliszyn-Moskal A., Klimiuk P.A., Sierakowski S., Ciolkiewicz M. Astudy on vascular endothelial growth factor and endothelin-1 in patients with extra-articular involvement of rheumatoid arthritis. Clin Rheumatol 2006, 25(3):314-319.
40. Usmani S.E., Appleton C.T., Beier F. Transforming growth factor-alpha induces endothelin receptor A expression in osteoarthritis. JOrthop Res 2012, 30(9):1391-1397.
41. Messai H., Khatib A.M., Lebrun G., Aubin P., Florina M., Jean F., et al. Endothelin-1 in monolayer cultures of articular chondrocytes from young and old rats: regulation by growth factors and cytokines. Mech Ageing Dev 2000, 114(1):37-48.
42. Wen C.Y., Yan C.H., Chung S.K., Chiu K.Y. Development of osteoarthritis-like changes in transgenic endothelin-1 over-expressed mice. The Thirteen International Conference on Endothelin Tokyo, Japan 2013.
43. Khatib A.M., Lomri A., Moldovan F., Soliman H., Fiet J., Mitrovic D.R. Endothelin 1 receptors, signal transduction and effects on DNA and proteoglycan synthesis in rat articular chondrocytes. Cytokine 1998, 10(9):669-679.
44. Khatib A.M., Siegfried G., Messai H., Moldovan F., Mitrovic D.R. Mechanism of inhibition of endothelin-1-stimulated proteoglycan and collagen synthesis in rat articular chondrocytes. Cytokine 2002, 17(5):254-261.
45. Yuan W., Zhao M.D., Yuan F.L., Che W., Duan P.G., Liu Y., et al. Association of endothelin-1 expression and cartilaginous endplate degeneration in humans. PLoS One 2013, 8(4):e60062.
46. Gokin A.P., Fareed M.U., Pan H.L., Hans G., Strichartz G.R., Davar G. Local injection of endothelin-1 produces pain-like behavior and excitation of nociceptors in rats. JNeurosci 2001, 21(14):5358-5366.
47. Griswold D.E., Douglas S.A., Martin L.D., Davis T.G., Davis L., Ao Z., et al. Endothelin B receptor modulates inflammatory pain and cutaneous inflammation. Mol Pharmacol 1999, 56(4):807-812.
48. Kaufman G.N., Zaouter C., Valteau B., Sirois P., Moldovan F. Nociceptive tolerance is improved by bradykinin receptor B1 antagonism and joint morphology is protected by both endothelin type A and bradykinin receptor B1 antagonism in a surgical model of osteoarthritis. Arthritis Res Ther 2011, 13(3).
49. Torres L., Dunlop D.D., Peterfy C., Guermazi A., Prasad P., Hayes K.W., et al. The relationship between specific tissue lesions and pain severity in persons with knee osteoarthritis. Osteoarthritis Cartilage 2006, 14(10):1033-1040.
50. Suri S., Gill S.E., Massena de Camin S., Wilson D., McWilliams D.F., Walsh D.A. Neurovascular invasion at the osteochondral junction and in osteophytes in osteoarthritis. Ann Rheum Dis 2007, 66(11):1423-1428.
51. Pecchi E., Priam S., Gosset M., Pigenet A., Sudre L., Laiguillon M.C., et al. Induction of nerve growth factor expression and release by mechanical and inflammatory stimuli in chondrocytes: possible involvement in osteoarthritis pain. Arthritis Res Ther 2014, 16(1):R16.
52. Ieda M., Fukuda K., Hisaka Y., Kimura K., Kawaguchi H., Fujita J., et al. Endothelin-1 regulates cardiac sympathetic innervation in the rodent heart by controlling nerve growth factor expression. JClin Invest 2004, 113(6):876-884.
53. Hunter D.J., Gerstenfeld L., Bishop G., Davis A.D., Mason Z.D., Einhorn T.A., et al. Bone marrow lesions from osteoarthritis knees are characterized by sclerotic bone that is less well mineralized. Arthritis Res Ther 2009, 11(1):R11.
54. Couchourel D., Aubry I., Delalandre A., Lavigne M., Martel-Pelletier J., Pelletier J.P., et al. Altered mineralization of human osteoarthritic osteoblasts is attributable to abnormal type I collagen production. Arthritis Rheum 2009, 60(5):1438-1450.
55. Sanchez C., Deberg M.A., Piccardi N., Msika P., Reginster J.Y., Henrotin Y.E. Subchondral bone osteoblasts induce phenotypic changes in human osteoarthritic chondrocytes. Osteoarthritis Cartilage 2005, 13(11):988-997.
56. Kurihara Y., Kurihara H., Suzuki H., Kodama T., Maemura K., Nagai R., et al. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 1994, 368(6473):703-710.
57. Kitano Y., Kurihara H., Kurihara Y., Maemura K., Ryo Y., Yazaki Y., et al. Gene expression of bone matrix proteins and endothelin receptors in endothelin-1-deficient mice revealed by in situ hybridization. JBone Min Res 1998, 13(2):237-244.
58. von Schroeder H.P., Veillette C.J., Payandeh J., Qureshi A., Heersche J.N. Endothelin-1 promotes osteoprogenitor proliferation and differentiation in fetal rat calvarial cell cultures. Bone 2003, 33(4):673-684.
59. Someya A., Yuyama H., Fujimori A., Ukai M., Fukushima S., Sasamata M. Effect of YM598, a selective endothelin ETA receptor antagonist, on endothelin-1-induced bone formation. Eur J Pharmacol 2006, 543(1-3):14-20.
60. Niger C., Geneau G., Fiorini C., Defamie N., Pointis G., Mesnil M., et al. Endothelin-1 inhibits human osteoblastic cell differentiation: influence of connexin-43 expression level. JCell Biochem 2008, 103(1):110-122.
61. Kasperk C.H., Borcsok I., Schairer H.U., Schneider U., Nawroth P.P., Niethard F.U., et al. Endothelin-1 is a potent regulator of human bone cell metabolism invitro. Calcif Tissue Int 1997, 60(4):368-374.
62. Hiruma Y., Inoue A., Shiohama A., Otsuka E., Hirose S., Yamaguchi A., et al. Endothelins inhibit the mineralization of osteoblastic MC3T3-E1 cells through the A-type endothelin receptor. Am J Physiol 1998, 275(4 Pt 2):R1099-R1105.
63. Shioide M., Noda M. Endothelin modulates osteopontin and osteocalcin messenger ribonucleic acid expression in rat osteoblastic osteosarcoma cells. JCell Biochem 1993, 53(2):176-180.
64. Lam H.C., Lee J.K., Lai K.H. Detection and characterization of endothelin in transformed human osteoblast cell culture medium. Endocrine 2000, 12(1):77-80.
65. Sasaki T., Hong M.H. Localization of endothelin-1 in the osteoclast. JElectron Microsc (Tokyo) 1993, 42(3):193-196.
66. Alam A.S., Gallagher A., Shankar V., Ghatei M.A., Datta H.K., Huang C.L., et al. Endothelin inhibits osteoclastic bone resorption by a direct effect on cell motility: implications for the vascular control of bone resorption. Endocrinology 1992, 130(6):3617-3624.
67. Drevensek M., Sprogar S., Boras I., Drevensek G. Effects of endothelin antagonist tezosentan on orthodontic tooth movement in rats. Am J Orthod Dentofac Orthop 2006, 129(4):555-558.
68. Sprogar S., Volk J., Drevensek M., Drevensek G. The effects of TBC3214, a selective endothelin ETA receptor antagonist, on orthodontic tooth movement in rats. Eur J Orthod 2007, 29(6):605-608.
69. Sprogar S., Vaupotic T., Cor A., Drevensek M., Drevensek G. The endothelin system mediates bone modeling in the late stage of orthodontic tooth movement in rats. Bone 2008, 43(4):740-747.
70. Nelson J.B., Hedican S.P., George D.J., Reddi A.H., Piantadosi S., Eisenberger M.A., et al. Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate. Nat Med 1995, 1(9):944-949.
71. Van Sant C., Wang G., Anderson M.G., Trask O.J., Lesniewski R., Semizarov D. Endothelin signaling in osteoblasts: global genome view and implication of the calcineurin/NFAT pathway. Mol Cancer Ther 2007, 6(1):253-261.
72. Carducci M.A., Jimeno A. Targeting bone metastasis in prostate cancer with endothelin receptor antagonists. Clin Cancer Res 2006, 12(20 Pt 2):6296s-6300s.
73. Clines G.A., Mohammad K.S., Bao Y., Stephens O.W., Suva L.J., Shaughnessy J.D., et al. Dickkopf homolog 1 mediates endothelin-1-stimulated new bone formation. Mol Endocrinol 2007, 21(2):486-498.
74. Simonet W.S., Lacey D.L., Dunstan C.R., Kelley M., Chang M.S., Luthy R., et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997, 89(2):309-319.
75. Hakimi M., Hyhlik-Durr A., von Au A., Betz M., Demirel S., Dihlmann S., et al. The expression of glycophorin A and osteoprotegerin is locally increased in carotid atherosclerotic lesions of symptomatic compared to asymptomatic patients. Int J Mol Med 2013, 32(2):331-338.
76. Agui T., Xin X., Cai Y., Sakai T., Matsumoto K. Stimulation of interleukin-6 production by endothelin in rat bone marrow-derived stromal cells. Blood 1994, 84(8):2531-2538.
77. Perkins S.L., Sarraj E., Kling S.J., Kohan D.E. Endothelin stimulates osteoblastic production of IL-6 but not macrophage colony-stimulating factor. Am J Physiol 1997, 272(3 Pt 1):E461-E468.
78. Kawamura H., Otsuka T., Tokuda H., Matsuno H., Niwa M., Matsui N., et al. Involvement of p42/p44 MAP kinase in endothelin-1-induced interleukin-6 synthesis in osteoblast-like cells. Bone 1999, 24(4):315-320.
79. Kozawa O., Kawamura H., Hatakeyama D., Matsuno H., Uematsu T. Endothelin-1 induces vascular endothelial growth factor synthesis in osteoblasts: involvement of p38 mitogen-activated protein kinase. Cell Signal 2000, 12(6):375-380.
80. Matsuno M., Kozawa O., Suzuki A., Tokuda H., Kaida T., Matsuno H., et al. Involvement of protein kinase C activation in endothelin-1-induced secretion of interleukin-6 in osteoblast-like cells. Cell Signal 1998, 10(2):107-111.
81. Tokuda H., Hanai Y., Matsushima-Nishiwaki R., Yamauchi J., Doi T., Harada A., et al. Rho-kinase regulates endothelin-1-stimulated IL-6 synthesis via p38 MAP kinase in osteoblasts. Biochem Biophys Res Commun 2007, 362(4):799-804.
82. Tokuda H., Takai S., Hanai Y., Matsushima-Nishiwaki R., Hosoi T., Harada A., et al. (-)-Epigallocatechin gallate suppresses endothelin-1-induced interleukin-6 synthesis in osteoblasts: inhibition of p44/p42 MAP kinase activation. FEBS Lett 2007, 581(7):1311-1316.
83. Takuwa Y., Masaki T., Yamashita K. The effects of the endothelin family peptides on cultured osteoblastic cells from rat calvariae. Biochem Biophys Res Commun 1990, 170(3):998-1005.
84. Suzuki A., Oiso Y., Kozawa O. Effect of endothelin-1 on phospholipase D activity in osteoblast-like cells. Mol Cell Endocrinol 1994, 105(2):193-196.
85. Takuwa Y., Ohue Y., Takuwa N., Yamashita K. Endothelin-1 activates phospholipase C and mobilizes Ca2+ from extra- and intracellular pools in osteoblastic cells. Am J Physiol 1989, 257(6 Pt 1):E797-E803.
86. Bouallegue A., Daou G.B., Srivastava A.K. Endothelin-1-induced signaling pathways in vascular smooth muscle cells. Curr Vasc Pharmacol 2007, 5(1):45-52.
87. Miyasaka N., Hirata Y., Ando K., Sato K., Morita H., Shichiri M., et al. Increased production of endothelin-1 in patients with inflammatory arthritides. Arthritis Rheum 1992, 35(4):397-400.
88. Kitten A.M., Andrews C.J. Endothelin-1 expression in long-term cultures of fetal rat calvarial osteoblasts: regulation by BMP-7. JCell Physiol 2001, 187(2):218-225.
89. Masukawa H., Miura Y., Sato I., Oiso Y., Suzuki A. Stimulatory effect of endothelin-1 on Na-dependent phosphate transport and its signaling mechanism in osteoblast-like cells. JCell Biochem 2001, 83(1):47-55.
90. Windischhofer W., Zach D., Fauler G., Raspotnig G., Kofeler H., Leis H.J. Involvement of Rho and p38 MAPK in endothelin-1-induced expression of PGHS-2 mRNA in osteoblast-like cells. JBone Min Res 2002, 17(10):1774-1784.
91. Semler D.E., Ohlstein E.H., Nambi P., Slater C., Stern P.H. Endothelin-1-evoked calcium transients in Umr-106 osteoblastic osteosarcoma cells are mediated through endothelin-a and endothelin-B receptors. JPharmacol Exp Ther 1995, 272(3):1052-1058.
92. Schvartz I., Ittoop O., Davidai G., Hazum E. Endothelin rapidly stimulates tyrosine phosphorylation in osteoblast-like cells. Peptides 1992, 13(1):159-163.
93. Suzuki A., Shinoda J., Watanabe-Tomita Y., Ozaki N., Oiso Y., Kozawa O. ETA receptor mediates the signaling of endothelin-1 in osteoblast-like cells. Bone 1997, 21(2):143-146.